Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-17

Clinical Trial Update: Fr1da Early Diagnosis and Care of Type 1 Diabetes

View source ↗

Summary

The Fr1da study, sponsored by Helmholtz Zentrum München, investigates early diagnosis and care of Type 1 Diabetes Mellitus and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Helmholtz Zentrum München | Conditions: Type 1 Diabetes Mellitus | Status: RECRUITING